WEISMAN HOWARD J. (Chief Executive Officer) sold 0.4% of their position (162.00 shares) of KUVATRIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $166.24 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/29/2023ACC: 0001062993-23-021596
DirectorOfficer· Chief Executive Officer
Since Aug 2022
-162.00
Net shares
Net seller
$166.24
Total sold
1
Open market trades
0B · 1S
1
Total transactions
162.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−162.00
Price / share
$1.03
Trade value
$166.24
% of position
0.4%
11/27/2023
38.21K→38.05K
Total
Net shares
−162.00
Net value
-$166.24
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/27/2023 | S · Sale | −162.00 | $1.03 | $166.24 | 0.4% | 38.21K | 38.05K |
| Total | −162.00 | -$166.24 | ||||||
Derivative Transactions0
No derivative transactions reported